REGISTER NOW:  Caris POA Molecular Summit Meeting

On Thursday, June 1 from 4:30-7:00 PM CT, the Caris POA will be holding its 9th Annual Molecular Summit Meeting at VenueSIX in downtown Chicago. The event is open to all POA members and will consist of a lively discussion on a variety of topics including Caris AI signatures, the Caris product pipeline, and Caris’ corporate commitment. This year’s keynote speaker is ASCO’s Chief Medical Officer Dr. Julie Gralow who will address “ASCO’s Commitment to Precision Oncology.”

If you would like to register for this event or forward the invitation to a colleague, please click on one of the links below.

To register, click here.
To download or forward the invitation to a colleague, click here.

“NEW” Community Oncology Working Group

On March 28, the Caris Precision Oncology Alliance will launch its 19th working group, Community Oncology. The Community Oncology working group is the first of three new groups slated for 2023, with ChIP and Pathogen launching later this year.

As a member of the POA, you are invited and encouraged to participate in any and all of these
groups based on your interest. The groups meet regularly and focus on research strategies, publication activities, and protocol development within the disease state of interest. Participating in these virtual meetings allows for improved collaboration, increased publication productivity, and better peer exchange.

To register for any of these groups please click here.

Caris POA Welcomes 2 New Members

2023 has been off to a fast start for the Caris POA with the addition of two new members: University of Chicago Comprehensive Center and University of California, Irvine – Chao Family Comprehensive Center

When the Caris POA was formed in 2015, our goal was to become the leading cancer research enterprise in the world. We knew in order to accomplish this we had to partner with institutions who put patients at the center of their practice, were not just leaders in oncology but in academic research, community care and clinical R&D. Through our collaborative efforts to truly revolutionize cancer care will we truly deliver greater molecular science solutions to improve the lives of cancer patients everywhere.

University of Chicago Comprehensive Cancer Center: The mission of the University of Chicago Medicine Comprehensive Cancer Center is to discover the determinants of cancer, develop novel therapies for cancer, and prevent cancer through innovative and collaborative research, compassionate patient care, education, and community engagement. The UChicago Medicine Cancer Center has been listed in U.S. News & World Report as one of  “America’s Best Hospitals” for cancer since 1999. Read more.

University of California, Irvine – Chao Family Comprehensive Center: The Chao Family Comprehensive Cancer Center is at the forefront of discovering new ways to fight cancer. As one of only 53 NCI-designated comprehensive cancer centers in the nation, the center combines leading-edge research, clinical trials and world-class care for patients. In 2020 alone, more than 7,250 new patients benefited from the advanced treatments provided by the center. Read more.

Caris POA Recognizes Incoming and Departing Chairs

Six members of the Caris POA will be finishing their tenure as working group Chairs this summer. Their support, dedication and contributions will be duly recognized at this year’s 9th Annual Molecular Summit Meeting. A special thank you to our outgoing Chairpersons and a warm welcome to the six that will be filling their roles: